Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II adjuvant and concurrent chemoradiotherapy trial in locally advanced gastric cancer after radical surgery
ChiCTR-TRC-13003229Phase 2Completed
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jun 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel, cisplatin, oxaliplatin, fluorouracil and folinic acid in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoint: Disease-free survival. Started Jun 2013; status: completed.
02
Drugs
docetaxelcisplatinoxaliplatinfluorouracilfolinic acid
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-13003229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003229.